Despite the high frequency of BNIP3 overexpression in tumor specimens, according to 5-year survival, BNIP3 is not correlated with survival probability in patients with different stages of lung cancer and its subtypes, including lung AD and SCC [73]. This evidence concerns the gene BNIP3 and neoplasm.